{"entity":{"type":"insider","cik":"0001534357","url":"/insider/0001534357","json_url":"/insider/0001534357.json","name":"Vos Ellen O'Connor","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":9,"first":"2017-05-31","last":"2023-07-26","span_basis":"filed_date"},"name_variants":[{"name":"Vos Ellen O'Connor","source":"filing","n_filings":9,"first_seen":"2017-05-31","last_seen":"2023-07-26"}],"transactions":[{"id":8310165,"accession":"0000926617-23-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000926617-23-000061","line_url":"/filing/0000926617-23-000061#line-1","is_derivative":false,"issuer_cik":"0000926617","issuer_name":"Aspira Women's Health Inc.","issuer_ticker":"AWH","issuer_name_source":null,"issuer_url":"/issuer/0000926617","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3769.0,"shares_display":"3,769","price_per_share":3.98,"price_display":"3.98","price_state":"stated","total_value":15000.62,"total_display":"15,000.62","total_whole":"15,001","shares_owned_after":32878.0,"shares_owned_after_display":"32,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-24","filed_date":"2023-07-26","scope":"insider"},{"id":6498296,"accession":"0001213900-22-049031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-049031","line_url":"/filing/0001213900-22-049031#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":15.91,"price_display":"15.91","price_state":"stated","total_value":7955.0,"total_display":"7,955.00","total_whole":"7,955","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":5458014,"accession":"0001019056-21-000555","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019056-21-000555","line_url":"/filing/0001019056-21-000555#line-1","is_derivative":false,"issuer_cik":"0001074871","issuer_name":"Modular Medical, Inc.","issuer_ticker":"MODD","issuer_name_source":null,"issuer_url":"/issuer/0001074871","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55555.0,"shares_display":"55,555","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":149998.5,"total_display":"149,998.50","total_whole":"149,999","shares_owned_after":61562.0,"shares_owned_after_display":"61,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-28","filed_date":"2021-11-01","scope":"insider"},{"id":2296419,"accession":"0001213900-20-008316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-20-008316","line_url":"/filing/0001213900-20-008316#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":8750.0,"total_display":"8,750.00","total_whole":"8,750","shares_owned_after":28022.0,"shares_owned_after_display":"28,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-31","filed_date":"2020-04-01","scope":"insider"},{"id":7845968,"accession":"0001213900-19-023370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-023370","line_url":"/filing/0001213900-19-023370#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":9.62,"price_display":"9.62","price_state":"stated","total_value":5772.0,"total_display":"5,772.00","total_whole":"5,772","shares_owned_after":22154.0,"shares_owned_after_display":"22,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-14","scope":"insider"},{"id":6635992,"accession":"0001213900-18-013770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-013770","line_url":"/filing/0001213900-18-013770#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2084.0,"shares_display":"2,084","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":15302.0,"shares_owned_after_display":"15,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-08","filed_date":"2018-10-10","scope":"insider"},{"id":6870591,"accession":"0001213900-18-008681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-008681","line_url":"/filing/0001213900-18-008681#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2084.0,"shares_display":"2,084","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":13218.0,"shares_owned_after_display":"13,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-29","filed_date":"2018-07-03","scope":"insider"},{"id":6870587,"accession":"0001213900-18-008317","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-18-008317","line_url":"/filing/0001213900-18-008317","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1350.0,"shares_display":"1,350","price_per_share":10.516296296296296,"price_display":"10.52","price_state":"stated","total_value":14197.0,"total_display":"14,197.00","total_whole":"14,197","shares_owned_after":10884.0,"shares_owned_after_display":"10,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-27","scope":"insider","n_lines":2},{"id":6870579,"accession":"0001213900-18-008317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-008317","line_url":"/filing/0001213900-18-008317","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":10.343333333333334,"price_display":"10.34","price_state":"stated","total_value":4654.5,"total_display":"4,654.50","total_whole":"4,655","shares_owned_after":9734.0,"shares_owned_after_display":"9,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-22","filed_date":"2018-06-27","scope":"insider","n_lines":2},{"id":4632163,"accession":"0001213900-17-006023","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-22","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":750.0,"total_display":"750.00","total_whole":"750","shares_owned_after":28000.0,"shares_owned_after_display":"28,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-03","filed_date":"2017-05-31","scope":"insider"},{"id":4632159,"accession":"0001213900-17-006023","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-21","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.74,"price_display":"0.74","price_state":"stated","total_value":1480.0,"total_display":"1,480.00","total_whole":"1,480","shares_owned_after":27000.0,"shares_owned_after_display":"27,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-12","filed_date":"2017-05-31","scope":"insider"},{"id":4632153,"accession":"0001213900-17-006023","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-20","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":810.0,"total_display":"810.00","total_whole":"810","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-24","filed_date":"2017-05-31","scope":"insider"},{"id":4632148,"accession":"0001213900-17-006023","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-19","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":810.0,"total_display":"810.00","total_whole":"810","shares_owned_after":24000.0,"shares_owned_after_display":"24,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-23","filed_date":"2017-05-31","scope":"insider"},{"id":4632144,"accession":"0001213900-17-006023","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-18","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":1620.0,"total_display":"1,620.00","total_whole":"1,620","shares_owned_after":23000.0,"shares_owned_after_display":"23,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-22","filed_date":"2017-05-31","scope":"insider"},{"id":4632141,"accession":"0001213900-17-006023","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-17","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":800.0,"total_display":"800.00","total_whole":"800","shares_owned_after":21000.0,"shares_owned_after_display":"21,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-21","filed_date":"2017-05-31","scope":"insider"},{"id":4632138,"accession":"0001213900-17-006023","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-16","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":810.0,"total_display":"810.00","total_whole":"810","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-05-31","scope":"insider"},{"id":4632133,"accession":"0001213900-17-006023","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-15","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":810.0,"total_display":"810.00","total_whole":"810","shares_owned_after":19000.0,"shares_owned_after_display":"19,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-05-31","scope":"insider"},{"id":4632126,"accession":"0001213900-17-006023","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-14","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":1640.0,"total_display":"1,640.00","total_whole":"1,640","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-05-31","scope":"insider"},{"id":4632121,"accession":"0001213900-17-006023","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-13","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":850.0,"total_display":"850.00","total_whole":"850","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-05-31","scope":"insider"},{"id":4632117,"accession":"0001213900-17-006023","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-12","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":1620.0,"total_display":"1,620.00","total_whole":"1,620","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-13","filed_date":"2017-05-31","scope":"insider"},{"id":4632111,"accession":"0001213900-17-006023","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-11","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":810.0,"total_display":"810.00","total_whole":"810","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-10","filed_date":"2017-05-31","scope":"insider"},{"id":4632106,"accession":"0001213900-17-006023","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-10","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":850.0,"total_display":"850.00","total_whole":"850","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-06","filed_date":"2017-05-31","scope":"insider"},{"id":4632101,"accession":"0001213900-17-006023","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-9","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":700.0,"total_display":"700.00","total_whole":"700","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-05-31","scope":"insider"},{"id":4632096,"accession":"0001213900-17-006023","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-8","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":710.0,"total_display":"710.00","total_whole":"710","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-05-31","scope":"insider"},{"id":4632093,"accession":"0001213900-17-006023","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-7","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":750.0,"total_display":"750.00","total_whole":"750","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-21","filed_date":"2017-05-31","scope":"insider"},{"id":4632087,"accession":"0001213900-17-006023","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-6","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":770.0,"total_display":"770.00","total_whole":"770","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-05-31","scope":"insider"},{"id":4632083,"accession":"0001213900-17-006023","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-5","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-10","filed_date":"2017-05-31","scope":"insider"},{"id":4632078,"accession":"0001213900-17-006023","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-4","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-05-31","scope":"insider"},{"id":4632074,"accession":"0001213900-17-006023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.745,"price_display":"0.74","price_state":"stated","total_value":1490.0,"total_display":"1,490.00","total_whole":"1,490","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-08","filed_date":"2017-05-31","scope":"insider","n_lines":2},{"id":4632061,"accession":"0001213900-17-006023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-006023","line_url":"/filing/0001213900-17-006023#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001534357","owner_name":"Vos Ellen O'Connor","owner_display_name":"Vos Ellen O'Connor","owner_url":"/insider/0001534357","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":770.0,"total_display":"770.00","total_whole":"770","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-05-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":33,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000926617","name":"Aspira Women's Health Inc.","url":"/issuer/0000926617","role":"Director","n_filings":1,"first_seen":"2023-07-26","last_seen":"2023-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001448431","name":"OptimizeRx Corp","url":"/issuer/0001448431","role":"Director","n_filings":7,"first_seen":"2017-05-31","last_seen":"2022-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001074871","name":"Modular Medical, Inc.","url":"/issuer/0001074871","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2021-11-01","last_seen":"2021-11-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001534357","retrieved_at":"2026-08-25T12:57:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}